Cargando…
Complexities of pharmacogenomic interactions in cancer
Genetic and genomic alterations drive cancer development. However, they may also constitute vulnerabilities, including increased drug sensitivity, which could be harnessed for precision medicine purposes. We discuss the highly complex pharmacogenomic interactions that are beginning to be disentangle...
Autores principales: | Khanna, Kum Kum, Duijf, Pascal H.G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7199761/ https://www.ncbi.nlm.nih.gov/pubmed/32391427 http://dx.doi.org/10.1080/23723556.2020.1735910 |
Ejemplares similares
-
Peptidyl-prolyl isomerization for cytokinetic abscission: Fold and cut
por: van der Horst, Armando, et al.
Publicado: (2012) -
Interaction between somatic mutations and germline variants contributes to clinical heterogeneity in cancer
por: Musa, Julian, et al.
Publicado: (2019) -
Cellular immunotherapy directed against human cytomegalovirus as a novel approach for glioblastoma treatment
por: Schuessler, Andrea, et al.
Publicado: (2014) -
A new approach for cellular immunotherapy of nasopharyngeal carcinoma
por: Smith, Corey, et al.
Publicado: (2012) -
BOK-MCL1 transmembrane interactions: a challenging target for cancer therapy
por: Sancho, Mónica, et al.
Publicado: (2021)